Literature DB >> 22144027

A methodical 68Ga-labelling study of DO2A-(butyl-L-tyrosine)2 with cation-exchanger post-processed 68Ga: practical aspects of radiolabelling.

Patrick J Riss1, Carsten Burchardt, Frank Roesch.   

Abstract

Positron emission tomography (PET) with (68)Ga is a fast-growing field in molecular imaging, both in research and in clinical routine. The availability of (68)Ga via the (68)Ge/(68)Ga radionuclide generator facilitates the development and production of radiopharmaceuticals independent of a cyclotron. The presented work shows a complete (68) Ga labelling study exemplified on [(68)Ga]DO2A-(butyl-L-tyrosine)(2), a potential tumour tracer for PET. A methodical sequence is followed to optimize the (68)Ga-labelling reaction. Practical aspects are described and the different parameters contributing to the labelling yield are demonstrated. The influence of temperature, time, amount of labelling precursor and pH value on the radiochemical yields is demonstrated. A conventional heating method is compared with microwave irradiation as an alternative labelling method. Finally, purification of (68)Ga-labelled compounds via solid-phase extraction and quality control is shown. The procedure described in this manuscript may serve as a guideline for optimizing (68)Ga labelling reactions.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22144027     DOI: 10.1002/cmmi.451

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


  5 in total

1.  Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time.

Authors:  Euy Sung Moon; Sanjana Ballal; Madhav Prasad Yadav; Chandrasekhar Bal; Yentl Van Rymenant; Sarah Stephan; An Bracke; Pieter Van der Veken; Ingrid De Meester; Frank Roesch
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-12-15

2.  Evaluation of a PACAP Peptide Analogue Labeled with (68)Ga Using Two Different Chelating Agents.

Authors:  Pardeep Kumar; Sushil Kumar Tripathi; Chang-Po Chen; Neil Mehta; Bishnuhari Paudyal; Eric Wickstrom; Mathew L Thakur
Journal:  Cancer Biother Radiopharm       Date:  2016-02       Impact factor: 3.099

3.  (177)Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatment.

Authors:  Ralf Bergmann; Marian Meckel; Vojtěch Kubíček; Jens Pietzsch; Jörg Steinbach; Petr Hermann; Frank Rösch
Journal:  EJNMMI Res       Date:  2016-01-16       Impact factor: 3.138

4.  NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye.

Authors:  Caiqin Zhang; Yong Zhao; Ningning Zhao; Dengxu Tan; He Zhang; Xue Chen; Hai Zhang; Jiaze An; Changhong Shi; Mengbin Li
Journal:  Contrast Media Mol Imaging       Date:  2018-03-08       Impact factor: 3.161

5.  Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer.

Authors:  Elisabeth Eppard; Ana de la Fuente; Martina Benešová; Ambreen Khawar; Ralph A Bundschuh; Florian C Gärtner; Barbara Kreppel; Klaus Kopka; Markus Essler; Frank Rösch
Journal:  Theranostics       Date:  2017-09-26       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.